9Bio Therapeutics
PrivateLast Round
Accelerator
Jun 23, 2025
Total Funding Raised
$429,000
Company Overview
9Bio Therapeutics is a biotechnology company that develops oncology therapeutics using its AI-guided structural biology platform to design drugs that selectively target tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
9Bio Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
9Bio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 23, 2025 | ||||
| Grant | Mar 20, 2025 | ||||
| Accelerator | May 21, 2024 |
9Bio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Merck Digital Sciences Studio | Accelerator |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| adMare BioInnovations | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 154% MoM.
- Jun 23, 2025
$100K round led by Merck Digital Sciences Studio
9Bio Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 9Bio Therapeutics's valuation, stock price, and market status.